CO015 | EVOLUTION OF ANTICOAGULANT THERAPY FOR CANCER-ASSOCIATED THROMBOSIS: THE START2 REGISTRY ONCO-VTE LONGITUDINAL STUDY
Background. Managing anticoagulant therapy in cancer-associated thrombosis (CAT) remains a clinical challenge, balanced between the heightened risks of recurrent venous thromboembolism (VTE) and major bleeding. The START2 Registry ONCO-VTE provides prospective, real-world evidence from patients with active malignancies...